Soleno Therapeutics (SLNO) had the highest return between August 15, 2023 and January 4, 2024 by a mid-cap US stock, returning 697.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 8/15/2023 - 1/4/2024 | 697.83% |
Immunitybio (IBRX) | 8/15/2023 - 1/4/2024 | 162.5% |
Scholar Rock (SRRK) | 8/15/2023 - 1/4/2024 | 142.9% |
Abercrombie & Fitch (ANF) | 8/15/2023 - 1/4/2024 | 124.08% |
Crinetics Pharmaceuticals (CRNX) | 8/15/2023 - 1/4/2024 | 106.96% |
Gap (GAP) | 8/15/2023 - 1/4/2024 | 98.95% |
Xometry (XMTR) | 8/15/2023 - 1/4/2024 | 97.02% |
Spyre Therapeutics (SYRE) | 8/15/2023 - 1/4/2024 | 96% |
Bitfarms (KEEL) | 8/15/2023 - 1/4/2024 | 92.76% |
Alpha Metallurgical Resources (AMR) | 8/15/2023 - 1/4/2024 | 92.12% |
TAL Education (TAL) | 8/15/2023 - 1/4/2024 | 87.63% |
Compania de Minas Buenaventura SAA ADR (BVN) | 8/15/2023 - 1/4/2024 | 87.34% |
Immunovant (IMVT) | 8/15/2023 - 1/4/2024 | 82.93% |
Belite Bio Inc ADR (BLTE) | 8/15/2023 - 1/4/2024 | 80.45% |
Apellis Pharmaceuticals (APLS) | 8/15/2023 - 1/4/2024 | 79.83% |
Dyne Therapeutics (DYN) | 8/15/2023 - 1/4/2024 | 77.4% |
Liquidia Technologies (LQDA) | 8/15/2023 - 1/4/2024 | 75.57% |
Ondas (ONDS) | 8/15/2023 - 1/4/2024 | 72.12% |
Uranium Energy (UEC) | 8/15/2023 - 1/4/2024 | 70.18% |
Elastic (ESTC) | 8/15/2023 - 1/4/2024 | 69.83% |
Nuvalent (NUVL) | 8/15/2023 - 1/4/2024 | 69.6% |
CleanSpark (CLSK) | 8/15/2023 - 1/4/2024 | 66.31% |
Rhythm Pharmaceuticals (RYTM) | 8/15/2023 - 1/4/2024 | 63% |
Praxis Precision Medicines (PRAX) | 8/15/2023 - 1/4/2024 | 62.88% |
TG Therapeutics (TGTX) | 8/15/2023 - 1/4/2024 | 62.64% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.